Anwar MM, Fathi MH (2023) Early approaches of YKL-40 as a biomarker and therapeutic target for Parkinson’s disease. Neurodegener Dis Manag 13(2):85–99. https://doi.org/10.2217/nmt-2022-0010

Article  CAS  PubMed  Google Scholar 

Atik A, Stewart T, Zhang J (2016) Alpha-synuclein as a biomarker for Parkinson’s disease. Brain Pathol 26(3):410–418. https://doi.org/10.1111/bpa.12370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baggio HC, Abos A, Segura B, Campabadal A, Uribe C, Giraldo DM, Perez-Soriano A, Munoz E, Compta Y, Junque C, Marti MJ (2019) Cerebellar resting-state functional connectivity in Parkinson’s disease and multiple system atrophy: characterization of abnormalities and potential for differential diagnosis at the single-patient level. Neuroimage Clin 22:101720. https://doi.org/10.1016/j.nicl.2019.101720

Article  PubMed  PubMed Central  Google Scholar 

Canaslan S, Schmitz M, Villar-Pique A, Maass F, Gmitterova K, Varges D, Lingor P, Llorens F, Hermann P, Zerr I (2021) Detection of cerebrospinal fluid neurofilament light chain as a marker for alpha-synucleinopathies. Front Aging Neurosci 13:717930. https://doi.org/10.3389/fnagi.2021.717930

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen WR, Chen JC, Chang SY, Chao CT, Wu YR, Chen CM, Chou C (2022) Phosphorylated alpha-synuclein in diluted human serum as a biomarker for Parkinson’s disease. Biomed J 45(6):914–922. https://doi.org/10.1016/j.bj.2021.12.010

Article  CAS  PubMed  Google Scholar 

Chen B, Cui W, Wang S, Sun A, Yu H, Liu Y, He J, Fan G (2023) Functional connectome automatically differentiates multiple system atrophy (parkinsonian type) from idiopathic Parkinson’s disease at early stages. Hum Brain Mapp 44(6):2176–2190. https://doi.org/10.1002/hbm.26201

Article  PubMed  PubMed Central  Google Scholar 

Chou KL, Dayalu P, Koeppe RA, Gilman S, Spears CC, Albin RL, Kotagal V (2022) Serotonin transporter imaging in multiple system atrophy and Parkinson’s disease. Mov Disord 37(11):2301–2307. https://doi.org/10.1002/mds.29220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E (2021) Cerebrospinal fluid alpha-synuclein species in cognitive and movements disorders. Brain Sci. https://doi.org/10.3390/brainsci11010119

Article  PubMed  PubMed Central  Google Scholar 

De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E, De Cecco E, Narkiewicz J, Salzano G, Carletta O, Romito L, Devigili G, Soliveri P, Tiraboschi P, Legname G, Tagliavini F, Eleopra R, Giaccone G, Moda F (2019) Efficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy. Transl Neurodegener 8:24. https://doi.org/10.1186/s40035-019-0164-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Luca CMG, Consonni A, Cazzaniga FA, Bistaffa E, Bufano G, Quitarrini G, Celauro L, Legname G, Eleopra R, Baggi F, Giaccone G, Moda F (2021) The alpha-synuclein RT-QuIC products generated by the olfactory mucosa of patients with Parkinson’s disease and multiple system atrophy induce inflammatory responses in SH-SY5Y cells. Cells. https://doi.org/10.3390/cells11010087

Article  PubMed  PubMed Central  Google Scholar 

Donadio V, Incensi A, Rizzo G, De Micco R, Tessitore A, Devigili G, Del Sorbo F, Bonvegna S, Infante R, Magnani M, Zenesini C, Vignatelli L, Cilia R, Eleopra R, Tedeschi G, Liguori R (2020) Skin biopsy may help to distinguish multiple system atrophy-parkinsonism from Parkinson’s disease with orthostatic hypotension. Mov Disord 35(9):1649–1657. https://doi.org/10.1002/mds.28126

Article  CAS  PubMed  Google Scholar 

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson’s disease and dementia with lewy bodies. Neurobiol Dis 45(1):188–195. https://doi.org/10.1016/j.nbd.2011.08.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gevezova M, Kazakova M, Trenova A, Sarafian V (2023) YKL-40 and the cellular metabolic profile in Parkinson’s Disease. Int J Mol Sci. https://doi.org/10.3390/ijms242216297

Article  PubMed  PubMed Central  Google Scholar 

Haga R, Sugimoto K, Nishijima H, Miki Y, Suzuki C, Wakabayashi K, Baba M, Yagihashi S, Tomiyama M (2015) Clinical utility of skin biopsy in differentiating between Parkinson’s disease and multiple system atrophy. Parkinsons Dis 2015:167038. https://doi.org/10.1155/2015/167038

Article  PubMed  PubMed Central  Google Scholar 

Hatanaka M, Hara K, Ohba C, Suzuki M, Ogura A, Kawabata K, Ito Y, Tada T, Fujita N, Mori D, Maesawa S, Kato K, Katsuno M (2025) Combined quantitative analysis of the nigro-striata system in multiple system atrophy and Parkinson’s disease. J Neurol Sci 468:123331. https://doi.org/10.1016/j.jns.2024.123331

Article  CAS  PubMed  Google Scholar 

Kerestes R, Laansma MA, Owens-Walton C, Perry A, van Heese EM, Al-Bachari S, Anderson TJ, Assogna F, Aventurato IK, van Balkom TD, Berendse HW, van den Berg KRE, Betts R, Brioschi R, Carr J, Cendes F, Clark LR, Dalrymple-Alford JC, Dirkx MF, Druzgal J, Durrant H, Emsley HCA, Garraux G, Haroon HA, Helmich RC, van den Heuvel OA, Joao RB, Johansson ME, Khachatryan SG, Lochner C, McMillan CT, Melzer TR, Mosley PE, Newman B, Opriessnig P, Parkes LM, Pellicano C, Piras F, Pitcher TL, Poston KL, Rango M, Roos A, Rummel C, Schmidt R, Schwingenschuh P, Silva LS, Smith V, Squarcina L, Stein DJ, Tavadyan Z, Tsai CC, Vecchio D, Vriend C, Wang JJ, Wiest R, Yasuda CL, Young CB, Jahanshad N, Thompson PM, van der Werf YD, Harding IH, Study EN-Ps (2023) Cerebellar volume and disease staging in Parkinson’s disease: an ENIGMA-PD study. Mov Disord 38(12):2269–2281. https://doi.org/10.1002/mds.29611

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HJ, Jeon BS, Jellinger KA (2015) Diagnosis and differential diagnosis of MSA: boundary issues. J Neurol 262(8):1801–1813. https://doi.org/10.1007/s00415-015-7654-2

Article  PubMed  Google Scholar 

Krismer F, Peran P, Beliveau V, Seppi K, Arribarat G, Pavy-Le Traon A, Meissner WG, Foubert-Samier A, Fabbri M, Schocke MM, Gordon MF, Wenning GK, Poewe W, Rascol O, Scherfler C (2024) Progressive brain atrophy in multiple system atrophy: a longitudinal, multicenter. Magn Reson Imaging Stud Mov Disord 39(1):119–129. https://doi.org/10.1002/mds.29633

Article  CAS  Google Scholar 

Lee EA, Cho HI, Kim SS, Lee WY (2004) Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 10(6):363–368. https://doi.org/10.1016/j.parkreldis.2004.04.008

Article  PubMed  Google Scholar 

Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy. J Neural Transm (Vienna) 113(10):1435–1439. https://doi.org/10.1007/s00702-005-0427-9

Article  CAS  PubMed  Google Scholar 

Li MG, Liu TF, Zhang TH, Chen ZY, Nie BB, Lou X, Wang ZF, Ma L (2020) Alterations of regional homogeneity in Parkinson’s disease with mild cognitive impairment: a preliminary resting-state fMRI study. Neuroradiology 62(3):327–334. https://doi.org/10.1007/s00234-019-02333-7

Article  PubMed  Google Scholar 

Li J, Liao H, Wang T, Zi Y, Zhang L, Wang M, Mao Z, Song C, Zhou F, Shen Q, Cai S, Tan C (2021) Alterations of regional homogeneity in the mild and moderate stages of Parkinson’s disease. Front Aging Neurosci 13:676899. https://doi.org/10.3389/fnagi.2021.676899

Article  PubMed  PubMed Central  Google Scholar 

Lin CH, Liu HC, Yang SY, Yang KC, Wu CC, Chiu MJ (2019) Plasma pS129-alpha-synuclein is a surrogate biofluid marker of motor severity and progression in Parkinson’s disease. J Clin Med. https://doi.org/10.3390/jcm8101601

Article  PubMed  PubMed Central  Google Scholar 

Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q, Pang D, Liu K, Jiang Q, Yang T, Xiao Y, Zhao B, Chen X, Song W, Yang J, Wu Y, Shang H (2023) Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson’s disease: a prospective cohort study. BMC Med 21(1):420. https://doi.org/10.1186/s12916-023-03120-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Jiang J, Zhou H, Zhang H, Wang M, Jiang J, Wu P, Ge J, Wang J, Ma Y, Zuo C (2020) Brain functional and structural signatures in Parkinson’s disease. Front Aging Neurosci 12:125. https://doi.org/10.3389/fnagi.2020.00125

Article  CAS  PubMed